You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
West Pharmaceutical Services announces Q2 dividend
21 February 2025 -

West Pharmaceutical Services Inc (NYSE: WST), a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products, on Thursday announced a dividend of USD0.21 per share for the second quarter of 2025.

This amount is unchanged from the first quarter dividend.

Shareholders of record at 30 April 2025 will receive the dividend on 7 May 2025.

Login
Username:

Password:


Related Headlines

Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion

ANI Pharmaceuticals announces buyout of royalty obligation for ILUVIEN and YUTIQ

Sirum collaborates with Governor Wes Moore to expand medication access across Maryland

Genomma Lab Internacional announces quarterly dividend

Abbott announces quarterly common dividend

West Pharmaceutical Services announces Q2 dividend

Perrigo increases quarterly dividend

AbbVie announces quarterly cash dividend

hVIVO acquires German Clinical Research Units for EUR10m; Targets earnings growth by 2026

OptiBiotix expands into Indian market with Amazon launch

Poxel to receive royalties and sales-based payment from Sumitomo Pharma

ReciBioPharm secures grant to expand RNA manufacturing in LMICs

CVS Health to pays common stock quarterly dividend of USD0.665 per share

TC BioPharm receives shareholders' approval for 25% stock dividend

USANA Health Sciences acquires controlling stake in Hiya Health for USD205m

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2025